Evidence map›Paper›PMID 35162295›Full record

Trial reportInternational journal of environmental research and public health2022

Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study.

Fulvio Adorni, Nithiya Jesuthasan, Elena Perdixi, Aleksandra Sojic, Andrea Giacomelli, Marianna Noale, Caterina Trevisan, Michela Franchini, Stefania Pieroni, Liliana Cori and 7 more

Abstract readClinical Trial, Phase II
In one paragraph

Trial report in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Observational
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Fulvio AdorniNational Research Council, Institute of Biomedical Technologies, Via Fratelli Cervi 93, 20054 Segrate, Italy.ORCID 0000-0001-6264-6876
Nithiya JesuthasanNational Research Council, Institute of Biomedical Technologies, Via Fratelli Cervi 93, 20054 Segrate, Italy.ORCID 0000-0001-7286-7234
Elena PerdixiNational Research Council, Institute of Biomedical Technologies, Via Fratelli Cervi 93, 20054 Segrate, Italy.
Aleksandra SojicNational Research Council, Institute of Biomedical Technologies, Via Fratelli Cervi 93, 20054 Segrate, Italy.ORCID 0000-0003-2318-4511
Andrea GiacomelliInfectious Diseases Unit, Department of Biomedical and Clinical Sciences L. Sacco, Università di Milano, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.ORCID 0000-0003-3685-4289
Marianna NoaleNational Research Council, Neuroscience Institute, Aging Branch, Via Vincenzo Maria Gallucci 16, 35128 Padova, Italy.ORCID 0000-0001-7115-139X
Caterina TrevisanGeriatric Unit, Department of Medicine (DIMED), University of Padova, Via Giustiniani 2, 35128 Padova, Italy.ORCID 0000-0002-9221-6997
Michela FranchiniNational Research Council, Institute of Clinical Physiology, Via G. Moruzzi 1, 56124 Pisa, Italy.ORCID 0000-0001-5272-341X
Stefania PieroniNational Research Council, Institute of Clinical Physiology, Via G. Moruzzi 1, 56124 Pisa, Italy.ORCID 0000-0002-8130-4967
Liliana CoriNational Research Council, Institute of Clinical Physiology, Via G. Moruzzi 1, 56124 Pisa, Italy.ORCID 0000-0002-3070-2535
Claudio Maria MastroianniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-1286-467X
Fabrizio BianchiNational Research Council, Institute of Clinical Physiology, Via G. Moruzzi 1, 56124 Pisa, Italy.ORCID 0000-0002-3459-9301
Raffaele Antonelli-IncalziUnit of Geriatrics, Department of Medicine, Biomedical Campus of Rome, 00128 Rome, Italy.ORCID 0000-0003-2100-2075
Stefania MaggiNational Research Council, Neuroscience Institute, Aging Branch, Via Vincenzo Maria Gallucci 16, 35128 Padova, Italy.ORCID 0000-0002-0453-8663
Massimo GalliInfectious Diseases Unit, Department of Biomedical and Clinical Sciences L. Sacco, Università di Milano, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.ORCID 0000-0001-8887-6215
Federica PrinelliNational Research Council, Institute of Biomedical Technologies, Via Fratelli Cervi 93, 20054 Segrate, Italy.ORCID 0000-0002-9093-7643
On Behalf Of The Epicovid Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Digital technologies have been extensively employed in response to the SARS-CoV-2 pandemic worldwide. This study describes the methodology of the two-phase internet-based EPICOVID19 survey, and the characteristics of the adult volunteer respondents who lived in Italy during the first (April-May 2020) and the second wave (January-February 2021) of the epidemic. Validated scales and ad hoc questionnaires were used to collect socio-demographic, medical and behavioural characteristics, as well as information on COVID-19. Among those who provided email addresses during phase I (105,355), 41,473 participated in phase II (mean age 50.7 years ± 13.5 SD, 60.6% females). After a median follow-up of ten months, 52.8% had undergone nasopharyngeal swab (NPS) testing and 13.2% had a positive result. More than 40% had undergone serological test (ST) and 11.9% were positive. Out of the 2073 participants with at least one positive ST, 72.8% had only negative results from NPS or never performed it. These results indicate that a large fraction of individuals remained undiagnosed, possibly contributing to the spread of the virus in the community. Participatory online surveys offer a unique opportunity to collect relevant data at individual level from large samples during confinement.

Indexed as

COVID-19AdultFemaleHumansInternetItalyMaleMiddle AgedPandemicsSARS-CoV-2Surveys and QuestionnairesCOVID-19observational studypublic healthSARS-CoV-2self-reported datatestingweb-based survey

Identifiers

PMID35162295
PMCPMC8835202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.